Asia-Pacific Americas Africa Europe Middle East

SN BIOSCIENCE

Company Profile:

SN BIOSCIENCE Company Introduction

SN BIOSCIENCE is a pharmaceutical and biotechnology company based in South Korea. It is primarily a **research and development focused pharmaceutical company** that also **manufactures its own innovative drug products**. Therefore, it functions as both a factory (manufacturer) and a developer, rather than solely a trading company.

The company specializes in developing novel drug delivery systems, particularly focusing on cancer therapies. Their core technology involves nanomedicine and polymer-drug conjugates designed to improve drug efficacy, reduce side effects, and overcome drug resistance for difficult-to-treat cancers. SN BIOSCIENCE aims to bring innovative cancer drugs to market globally.

Enterprise Products

SN Bioscience Products:

* SNB-101 (Paclitaxel Micelle): Anticancer drug

* SNB-102 (Docetaxel Micelle): Anticancer drug

* SNB-103 (SN38 Micelle): Anticancer drug

* Micelle Platform Technology: Drug delivery system

* Liposome Platform Technology: Drug delivery system

* Hyaluronic acid nanoparticle Platform Technology: Drug delivery system

* Exosome Platform Technology: Drug delivery system

Business Registration Information:

Manager:

Jaewon Lee
Phone:

+82-31-696-0350
E-mail:

info@snbioscience.com
Official Website:
Address:

B-601, 7, Pangyo-ro 255beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.